A-gamma globin 2026-11-05
A-gamma globin is the human HBG1 gene product, a form of gamma-globin with alanine at residue 136. Its name contrasts with G-gamma globin, whose corresponding residue is glycine. Both belong to the gamma-chain class used in fetal hemoglobin.[ref]
Human globin gene records in NCBI Gene. HBG1, Gene 3047, RefSeq Summary, alanine/glycine distinction at residue 136
A-gamma is not hemoglobin A: the latter is the adult assembly containing beta-globin.A single changed amino acid residue can supply a useful analytical signature without changing which general globin class is being measured. Replacing glycine with alanine adds the elemental composition , since their side chains are hydrogen and methyl. In a deliberately nominal-mass calculation this adds about 14 unified atomic mass units. If an otherwise identical diagnostic peptide produces ions with charge number , the expected separation in mass-to-charge ratio is approximatelyFor , that is about seven mass-to-charge units. This is a proposed analytical discrimination, not the experimental method used in the historical paper. Actual mass spectrometry must use the appropriate exact masses and account for other sequence changes, isotope peaks and modifications.
A sequence-selective amount measurement also requires a response model. In an original two-channel example, suppose one pmol of each form produces detector responses and in arbitrary signal units. Signals and correspond to amounts 20 and 60 pmol, giving an A-gamma fractionUsing the raw signal fraction would instead give 0.40. A distinct molecular signature identifies a channel; it does not guarantee equal analytical response between channels.
The 1968 primary study reported the additional alanine-containing form at position 136 in human fetal hemoglobin components.[ref]
Evidence for multiple structural genes for the gamma chain of human fetal hemoglobin by W. A. Schroeder and others. p.537, opening paragraph
That observation motivates distinguishing sequence forms experimentally, while HBG1 supplies their present gene-level identification. Neither an A-gamma amount nor its ratio to G-gamma alone establishes the oxygen-binding properties of every assembled tetramer. Anaphylatoxin 2026-11-05
An anaphylatoxin is a small signaling peptide released from a complement system component during activation. C3a and C5a are important examples: fragments derived from larger circulating proteins act as ligands for cell-surface receptors, connecting complement system activation with cellular responses involved in inflammation.[ref]
The historical name is best understood through measurements of activity. Viktor A. Bokisch and colleagues isolated C3a and measured its ability to contract smooth muscle. Its activity could be inhibited or lost without simply equating every Complement C3 fragment with the same effect. This supplies a concrete example of a protein cleavage product acquiring a signaling role distinguishable from the remainder of its precursor.[ref]
Isolation of a fragment (C3a) of the third component of human complement containing anaphylatoxin and chemotactic activity and description of an anaphylatoxin inactivator of human serum by Viktor A. Bokisch and others. Abstract: isolated C3a, smooth-muscle activity, antibody inhibition and inactivation.
Andrew P. Laudano 2026-11-05
Andrew P. Laudano is a biochemistry researcher whose work with Russell F. Doolittle used synthetic peptides to investigate fibrin assembly. A historical university catalog records his UC San Diego doctorate in 1981 and lists him as an emeritus faculty member in 2013–2014.[ref]
Andrew P. Laudano entry in the University of New Hampshire 2013–2014 faculty catalog. Laudano,AndrewP entry: degree and historical faculty classification
In the 1978 experiment, Gly-Pro-Arg-Pro bound fibrinogen and fragment D but not the central fragment E. The shorter Gly-Pro-Arg bound less tightly and inhibited polymerization less effectively. These comparisons linked the structure of a small peptide to its ability to disrupt a larger molecular assembly.[ref]
Synthetic peptide derivatives that bind to fibrinogen and prevent the polymerization of fibrin monomers by Andrew P. Laudano and Russell F. Doolittle. Abstract: fragment-specific binding and tripeptide/tetrapeptide comparison
An illuminating control is a fragment that does not bind: it helps localize the interacting region rather than merely showing that “some protein” captures the peptide. Comparing related sequences adds another constraint. Together the tests connect binding affinity, molecular location and the observable formation of a fibrin network.
Andrew Schally 2026-11-05
Andrew Schally studied how the hypothalamus controls secretion by the pituitary gland through small peptides. His work helped establish a chemical connection between brain activity and the release of hormones, and he shared the 1977 Nobel Prize in Physiology or Medicine for discoveries concerning brain peptide hormone production. He worked at Tulane and the Veterans Affairs hospital in New Orleans for more than four decades.[ref]
Dr. Andrew Schally, former Tulane endocrinologist and Nobel laureate, dies at 97 by Tulane University. institutional obituary, career and hypothalamic peptide research
One important experimental question was whether separate hypothalamic signals were needed for the two gonadotropins, luteinizing hormone and follicle-stimulating hormone. Schally and colleagues' 1971 report described a purified hypothalamic factor that stimulated both. This connected a chemically characterized signal to two measured pituitary gland responses and helped establish the role of gonadotropin-releasing hormone.[ref]
Portrait attributed to NASA in the Wikimedia Commons file record.
Antigen presentation Created 2026-10-20 Updated 2026-11-05
Display of antigen-derived material for immune recognition, including peptide display by MHC molecules to T-cell receptors. Processing, expression and recognition are distinct requirements.
Attenuation in bacterial gene regulation Created 2026-10-20 Updated 2026-11-05
Attenuation in bacterial gene regulation regulates downstream transcription through formation of alternative RNA structures during transcription. In the tryptophan example, biological translation of a leader peptide influences which structure forms; the immediate decision is transcription termination.
Bacteriocin 2026-11-05
A bacteriocin is an antimicrobial peptide or protein produced by bacteria that acts against susceptible bacterial strains. The category describes a biological product and its antibacterial action; susceptibility depends on both the product and the target.[ref]
Bacteriocins in NLM MeSH. D001430; original descriptor scope note
Colicin E1 supplies a concrete mechanistic example. An experiment compared the complete protein with its C-terminus fragment in artificial lipid bilayers. Similar channel properties in the two forms localized pore-forming activity to that region. Membrane association could occur without the membrane potential needed for conducting channels to form.[ref]
Comparison of the macroscopic and single channel conductance properties of colicin E1 and its COOH-terminal tryptic peptide by J. O. Bullock and others. Abstract; fragment comparison and potential dependence
The experiment shows how to separate delivery, attachment and action of a bacterial product. It establishes a channel mechanism for the tested Colicin E1 system; the class name bacteriocin does not assign that same mechanism to every member. A growth-inhibition observation alone would not identify which molecular step caused the inhibition.
Ball-and-chain inactivation Created 2026-10-25 Updated 2026-11-05
A tethered intracellular particle blocks an open ion channel from the cytoplasmic side. In classical Shaker-type channels the particle is N-terminal: removing it suppresses fast inactivation, while cytoplasmic application of a corresponding peptide can restore block. The pore-blocking mechanism differs from ordinary activation-gate closure.
Beta-2-microglobulin Created 2026-10-20 Updated 2026-11-05
Bottom-up proteomics 2026-10-20
Analysis of proteins after digestion into smaller peptides. It can provide broad sequence and modification coverage, but digestion commonly loses information about which distant variations occur together in an intact proteoform.
C5a 2026-11-05
C5a is a small peptide fragment derived from complement C5 and classified as an anaphylatoxin. It can act as a signaling ligand; the name identifies a processed product rather than the whole circulating precursor. The originating pharmacology record identifies human C5a as an endogenous ligand associated with inflammatory signaling.[ref]
Complement components and ligands in the Guide to Pharmacology. Family956 and ligand573: human C5a, endogenous peptide and anaphylatoxin classification
Historical experiments tied fragment isolation to biological activity. In 1968, researchers separated larger and smaller fractions from guinea pig complement C5. The smaller fraction attracted rabbit polymorphonuclear leukocytes and showed activity in a guinea pig ileum assay. Those observations concern specific assay systems, not a human clinical experiment.[ref]
Chemotactic and anaphylatoxic fragment cleaved from the fifth component of guinea pig complement by H. S. Shin and others. Primary Abstract: fraction separation, rabbit leukocyte chemotaxis and guinea-pig ileum response
For an original interpretation example, suppose equal amounts of two preparations are compared in both a chemotaxis assay and a smooth muscle response assay. Similar movement of leukocytes would not by itself establish equal smooth-muscle effects: the two readouts measure different responses. Conversely, detecting a fragment by an antibody does not guarantee that it retains either biological activity.
Capillary electrophoresis 2026-11-05
Capillary electrophoresis separates species by their motion in an electric field inside a narrow liquid-filled tube. In its free-solution form, different electrophoretic mobilities produce different drift speeds; a detector at a fixed position records the arriving bands as an electropherogram. The liquid itself can also move by electroosmotic flow, so arrival order is not determined by molecular charge alone.
A simple apparatus places the ends of a capillary in two buffer reservoirs containing electrodes. An applied electric potential difference drives migration along the tube; a detection window interrogates the passing material. In the uniform-field model, with total capillary length , detector distance and signed applied potential ,The last expression requires net motion towards the detector. Thus a neutral marker can move with electroosmotic flow even though its electrophoretic mobility is zero. The instrument's distinction between total length and detector distance matters when converting migration times into apparent mobility.[ref]
For an original ideal example, take , and . Two net mobilities give speeds and and migration times 250 and 200 s. These are model values, not assigned chemical identities. Band widths from diffusion, injection and other dispersion mechanisms determine whether the time difference is actually resolved.
Narrow tubes also help remove Joule heating. For a uniform cylindrical liquid conductor, heat generation per volume is , with electrical conductivity , while wall area per liquid volume is for tube radius . This geometric scaling motivates small bores, although temperature control still depends on heat transfer through the wall and surroundings. Increasing the electric field indefinitely is therefore not a free route to perfect separation.
A primary 1981 demonstration used a 1 m glass capillary with 75 micrometre internal diameter, a 30 kV applied potential and a fluorescence detector. It resolved fluorescent derivatives of amino acids, peptides and urinary amines. The observed result was separated fluorescent zones; the need to derivatize the samples was an explicit detection limitation.[ref]
Free-zone electrophoresis in glass capillaries by J. W. Jorgenson and K. D. Lukacs. Abstract, apparatus and demonstrated separations
CD4 Created 2026-10-20 Updated 2026-11-05
A coreceptor usually associated with recognition of peptide–MHC-class-II complexes. CD4 T-cell biological populations coordinate and regulate immune responses in addition to other context-dependent activities.
CD8 Created 2026-10-20 Updated 2026-11-05
A coreceptor associated with recognition of peptide–MHC-class-I complexes by cytotoxic T cells. It contributes to binding and signalling without replacing T-cell-receptor specificity.
Chimeric antigen receptor Created 2026-10-20 Updated 2026-11-05
CLE peptide Created 2026-10-20 Updated 2026-11-05
Codon Created 2026-10-14 Updated 2026-10-18
A codon is a three-nucleotide unit read in a specified reading frame during biological translation. For example, GCU specifies alanine in the standard genetic code. Its letters are read .
For an original example, choose the messenger RNA segment and stipulate initiation at the displayed AUG in a suitable eukaryotic context. Under the standard genetic code, its first three codons specify methionine, alanine and phenylalanine; the fourth is a stop codon. The resulting peptide before processing is N–methionine–alanine–phenylalanine–C. Twelve nucleotides therefore specify three amino acid residues and termination. The displayed segment omits the surrounding initiation signals; its nucleotide sequence alone is not a complete expression system.
A codon belongs to an oriented nucleotide sequence: GCU and UCG are different ordered triplets. Four possible nucleobases, adenine, cytosine, guanine and uracil, allow triplets because each position can be chosen independently when enumerating possible sequences. This is a counting argument, not a claim that nucleobases occur independently in real RNA. Sixty-one triplets are sense codons, meaning amino acid assignments, and UAA, UAG and UGA are stop codons in the standard genetic code.[ref]
Biology 2e by Mary Ann Clark and others. §15.1, The Genetic Code, Figure 15.4 and following paragraph: triplets and standard assignments
The useful unit is the ordered triplet together with its reading frame and genetic code, rather than three letters viewed in isolation. That combination lets DNA sequencing data support predictions about protein sequences after identifying the relevant messenger RNA. The Nirenberg and Matthaei experiment illustrates how the correspondence became experimentally accessible.
Collagen IV 2026-11-05
Collagen IV, also called type IV collagen, is the network-forming collagen that provides a major scaffold of basement membranes. Three polypeptide chains assemble into a molecular unit, and units associate through their ends into a sheet-like network. This organization suits a thin supporting layer beneath an epithelium, rather than a long cable made of parallel molecules.[ref]
A Sulfilimine Bond Identified in Collagen IV by Roberto Vanacore and others. Introduction and Figure3: protomers and basement-membrane network architecture
The Collagen IV NC1 domain is a noncollagenous end region where adjoining molecular units meet. A sulfilimine bond links a methionine side chain in one unit to a hydroxylysine side chain in another. Thus the scaffold combines molecular association with a chemically specific covalent bond.[ref]
A Sulfilimine Bond Identified in Collagen IV by Roberto Vanacore and others. Figures1–3: identification and placement of the crosslink
One can distinguish two questions about a basement membrane: which proteins form its scaffold, and how neighboring units are fastened together. Isolating linked peptides and comparing their mass spectrometry and nuclear magnetic resonance signals answered the second question. The investigation connected a tissue-scale network to the identities of individual amino acid residues.[ref]
A Sulfilimine Bond Identified in Collagen IV by Roberto Vanacore and others. Table1 and Figures1–2: crosslinked-peptide measurements
Collagen IV NC1 domain 2026-11-05
The Collagen IV NC1 domain is the noncollagenous protein domain at the C-terminus of a Collagen IV chain. NC1 regions participate in the end-to-end assembly of the network that supports a basement membrane. A three-chain Collagen IV protomer presents three NC1 regions at this end; association of two such ends forms a six-subunit Collagen IV NC1 hexamer.[ref]
A Sulfilimine Bond Identified in Collagen IV by Roberto Vanacore and others. Introduction and Figure 3; trimeric NC1 ends of adjoining protomers and hexamer organization
The counting is useful: a six-subunit junction joins two three-chain molecular units, rather than requiring each Collagen IV molecule to contain six chains. The Collagen IV NC1 hexamer describes a local meeting point in the larger scaffold.
The junction is reinforced by sulfilimine bonds between methionine and hydroxylysine residues of adjoining units. In 2009, mass spectrometry and nuclear magnetic resonance measurements on isolated linked peptides identified this bond. Chemical reduction separated the linked peptides, providing another test of the proposed structure. Up to six such links can reinforce the interface between the two NC1 ends.[ref]
Collagen IV NC1 hexamer 2026-11-05
A Collagen IV NC1 hexamer is a six-subunit junction formed when the C-terminus ends of two Collagen IV protomers associate. Each three-chain protomer contributes three Collagen IV NC1 domains. The resulting arrangement is therefore two three-subunit ends joined together, one local connection in a basement membrane scaffold.[ref]
A Sulfilimine Bond Identified in Collagen IV by Roberto Vanacore and others. Introduction and Figure 3; trimeric ends and six-subunit junction
Up to six sulfilimine bonds can reinforce the interface between the two ends. Analysis of linked peptides by mass spectrometry and nuclear magnetic resonance, followed by chemical reduction that separated the linked components, established the chemistry of this reinforcement.[ref]
A Sulfilimine Bond Identified in Collagen IV by Roberto Vanacore and others. Table 1 and Figures 1–3; crosslinked peptides, bond identification and reduction

